World's Best Scientists 2026 revealed!
Tsutomu Takeuchi

Tsutomu Takeuchi

D-Index & Metrics

Medicine

D-Index
105
Citations
54436
World Ranking
6680
National Ranking
155

Tsutomu Takeuchi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tsutomu Takeuchi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,144 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Tsutomu Takeuchi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tsutomu Takeuchi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 105 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Tsutomu Takeuchi is affiliated with Keio University in Japan and has a research focus primarily within the field of Medicine, with notable contributions to Rheumatology. Their scholarly work is concentrated on autoimmune and inflammatory disorders, particularly rheumatoid arthritis and systemic lupus erythematosus.

The scientist's publication record includes research addressing fundamental and clinical aspects of autoimmune diseases, with a strong emphasis on treatment strategies and therapeutic advancements.

Recent prominent papers include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update (2020, Annals of the Rheumatic Diseases)
  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update (2022, Annals of the Rheumatic Diseases)
  • Translating IL-6 biology into effective treatments (2020, Nature Reviews Rheumatology)
  • Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement (2020, Annals of the Rheumatic Diseases)
  • Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-Naive Patients With Moderately-to-Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Multicenter, Multi-Country, Randomized, Double-Blind, Active Comparator-Controlled Trial (2020, Arthritis & Rheumatology)

Frequent collaborators in research include:

  • Yoshiya Tanaka
  • Yuko Kaneko
  • Katsuya Suzuki
  • Jun Kikuchi
  • Masayoshi Harigai

Tsutomu Takeuchi's research is often disseminated through several key academic journals, notably:

  • Annals of the Rheumatic Diseases
  • Modern Rheumatology
  • Lara D. Veeken
  • Arthritis Research & Therapy
  • Arthritis & Rheumatology

Their work spans several subfields of study including:

  • Rheumatology
  • Genetics
  • Immunology
  • Hematology
  • Pathology and Forensic Medicine

Main topics covered by their research encompass:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Chronic Lymphocytic Leukemia Research
  • Autoimmune and Inflammatory Disorders Research
  • Lymphoma Diagnosis and Treatment
  • Monoclonal and Polyclonal Antibodies Research
  • Vasculitis and related conditions

Best Publications

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • Innate production of T H 2 cytokines by adipose tissue-associated c-Kit + Sca-1 + lymphoid cells

    Kazuyo Moro;Taketo Yamada;Masanobu Tanabe;Tsutomu Takeuchi

  • Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk

  • Treatment of rheumatoid arthritis with humanized anti–interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial

    Norihiro Nishimoto;Kazuyuki Yoshizaki;Nobuyuki Miyasaka;Kazuhiko Yamamoto

  • Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

    Norihiro Nishimoto;Jun Hashimoto;Nobuyuki Miyasaka;Kazuhiko Yamamoto

  • PI3K-mediated negative feedback regulation of IL-12 production in DCs

    Taro Fukao;Masanobu Tanabe;Yasuo Terauchi;Takayuki Ota

  • Translating IL-6 biology into effective treatments.

    Ernest Hs Choy;Fabrizio De Benedetti;Tsutomu Takeuchi;Misato Hashizume

  • Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy

    Norihiro Nishimoto;Nobuyuki Miyasaka;Kazuhiko Yamamoto;Shinichi Kawai

  • Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis

    Tsutomu Takeuchi;Y. Tatsuki;Y. Nogami;N. Ishiguro

  • An Evolutionarily Conserved Mechanism for MicroRNA-223 Expression Revealed by MicroRNA Gene Profiling

    Taro Fukao;Yoko Fukuda;Kotaro Kiga;Jafar Sharif

  • Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.

    Yoshihiko Hoshida;Jing Xian Xu;Shigeki Fujita;Itsuko Nakamichi

  • Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study

    Norihiro Nishimoto;Nobuyuki Miyasaka;Kazuhiko Yamamoto;Shinichi Kawai

  • Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment

    Roy Fleischmann;Michael Schiff;Désirée van der Heijde;Cesar Ramos-Remus

  • Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review

    Vibeke Strand;Alejandro Balsa;Jamal Al-Saleh;Leonor Barile-Fabris

  • Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells

    Masashi Ohtani;Shigenori Nagai;Shuhei Kondo;Shinta Mizuno

  • Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease.

    Masanori Kawashima;Masahiro Yamamura;Madoka Taniai;Hiroshi Yamauchi

  • Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

    Y Tanaka;T Takeuchi;T Mimori;K Saito

  • Effect of Filgotinib vs Placebo on Clinical Response in Patients with Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial

    Mark C. Genovese;Kenneth Kalunian;Jacques Eric Gottenberg;Neelufar Mozaffarian

  • Serum indicators for the diagnosis of pneumocystis pneumonia

    Sadatomo Tasaka;Naoki Hasegawa;Seiki Kobayashi;Wakako Yamada

  • Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.

    Hideto Kameda;Hayato Nagasawa;Hiroe Ogawa;Naoya Sekiguchi

Frequent Co-Authors

Yoshiya Tanaka
Yoshiya Tanaka University of Occupational and Environmental Health Japan
Hisashi Yamanaka
Hisashi Yamanaka International University of Health and Welfare
Nobuyuki Miyasaka
Nobuyuki Miyasaka Tokyo Medical and Dental University
Naoki Ishiguro
Naoki Ishiguro Nagoya University
Kazuo Tsubota
Kazuo Tsubota Keio University
Takao Koike
Takao Koike Hokkaido University
Masataka Kuwana
Masataka Kuwana Nippon Medical School
Tatsuya Atsumi
Tatsuya Atsumi Hokkaido University
Josef S. Smolen
Josef S. Smolen Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

With healthcare careers in high demand, there are diverse online education options for students interested in medical professions. Many pursue nursing through flexible pathways. For registered nurses seeking to advance, rn to bsn online programs offer an affordable way to earn a bachelor’s degree while working.

Others with a non-nursing background can make a fast transition via direct entry msn programs, designed to help career changers quickly gain advanced nursing credentials. Alternatively, those looking for the fastest entry into nursing may consider online adn programs for non nurses, which focus on associate degrees and have more flexible admissions.

If direct patient care is not your preference, there are other in-demand healthcare roles. online medical billing and coding with financial aid programs provide training in healthcare administration, billing, and records—a fast-growing field with a lower barrier to entry. Exploring these online degrees can help you find the right path in the medical field.

Best Scientists Citing Tsutomu Takeuchi

Trending Scientists

Recently Published Articles